Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA genetics panel

This article was originally published in The Gray Sheet

Executive Summary

Agency announces in a Sept. 27 Federal Register notice the formation of the Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee in the Center for Devices and Radiological Health and requests nominations for members to serve on the panel. Nominations of persons having expertise in human genetics, clinical management of patients with genetic disorders, training in biochemical and/or molecular genetics and experience in genetic counseling and medical ethics are due by October 27. The panel will be charged with providing advice to the FDA commissioner on appropriate scientific criteria to diagnostically test for human genes

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012345

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel